KRAS-specific Amino Acid Substitutions are Associated With Different Responses to Chemotherapy in Advanced Non–small-cell Lung Cancer-Reference-Cited by-同舟云学术

KRAS-specific Amino Acid Substitutions are Associated With Different Responses to Chemotherapy in Advanced Non–small-cell Lung Cancer

Published:2018-11 Issue:6 Volume:19 Page:e919-e931
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Renaud Stéphane,Guerrera Francesco^ORCID,Seitlinger Joseph,Reeb Jérémie,Voegeli Anne-Claire,Legrain Michèle,Mennecier Bertrand,Santelmo Nicola,Falcoz Pierre-Emmanuel,Quoix Elisabeth,Chenard Marie-Pierre,Weingertner Noëlle,Beau-Faller Michèle,Massard Gilbert

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference37 articles.

1. Lung cancer statistics;Torre;Adv Exp Med Biol,2016

2. Molecular biomarkers for lung adenocarcinoma;Calvayrac;Eur Respir J,2017

3. Correlation of histologic subtypes and molecular alterations in pulmonary adenocarcinoma: therapeutic and prognostic implications;Kim;Adv Anat Pathol,2016

4. EGFR gene deregulation mechanisms in lung adenocarcinoma: a molecular review;Tsiambas;Pathol Res Pract,2016

5. The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: status in 2016;Tan;J Thorac Oncol,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer;Signal Transduction and Targeted Therapy;2024-08-21

2. KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways;Cells;2024-07-19

3. A Critical Review of the Prognostic and Predictive Implications of KRAS and STK11 Mutations and Co-Mutations in Metastatic Non-Small Lung Cancer;Journal of Personalized Medicine;2023-06-18

4. RAS‐targeted cancer therapy: Advances in drugging specific mutations;MedComm;2023-05-27

5. A single center analysis of first-line treatment in advanced KRAS mutant non-small cell lung cancer: real-world practice;BMC Cancer;2022-11-14